These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17401097)

  • 1. Indication for different mechanisms of kidney uptake of radiolabeled peptides.
    Gotthardt M; van Eerd-Vismale J; Oyen WJ; de Jong M; Zhang H; Rolleman E; Maecke HR; Béhé M; Boerman O
    J Nucl Med; 2007 Apr; 48(4):596-601. PubMed ID: 17401097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing renal uptake of radiolabeled peptides using albumin fragments.
    Vegt E; van Eerd JE; Eek A; Oyen WJ; Wetzels JF; de Jong M; Russel FG; Masereeuw R; Gotthardt M; Boerman OC
    J Nucl Med; 2008 Sep; 49(9):1506-11. PubMed ID: 18703613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats.
    van Eerd JE; Vegt E; Wetzels JF; Russel FG; Masereeuw R; Corstens FH; Oyen WJ; Boerman OC
    J Nucl Med; 2006 Mar; 47(3):528-33. PubMed ID: 16513623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides.
    Vegt E; Eek A; Oyen WJ; de Jong M; Gotthardt M; Boerman OC
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):226-34. PubMed ID: 19722105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences.
    Melis M; Krenning EP; Bernard BF; de Visser M; Rolleman E; de Jong M
    Nucl Med Biol; 2007 Aug; 34(6):633-41. PubMed ID: 17707803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin.
    Vegt E; Wetzels JF; Russel FG; Masereeuw R; Boerman OC; van Eerd JE; Corstens FH; Oyen WJ
    J Nucl Med; 2006 Mar; 47(3):432-6. PubMed ID: 16513612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
    Wild D; Wicki A; Mansi R; Béhé M; Keil B; Bernhardt P; Christofori G; Ell PJ; Mäcke HR
    J Nucl Med; 2010 Jul; 51(7):1059-67. PubMed ID: 20595511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys.
    Béhé M; Kluge G; Becker W; Gotthardt M; Behr TM
    J Nucl Med; 2005 Jun; 46(6):1012-5. PubMed ID: 15937313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.
    Bernard BF; Krenning EP; Breeman WA; Rolleman EJ; Bakker WH; Visser TJ; Mäcke H; de Jong M
    J Nucl Med; 1997 Dec; 38(12):1929-33. PubMed ID: 9430472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro comparison of renal handling and uptake of two somatostatin receptor-specific peptides labeled with indium-111.
    Trejtnar F; Novy Z; Petrik M; Laznickova A; Melicharova L; Vankova M; Laznicek M
    Ann Nucl Med; 2008 Dec; 22(10):859-67. PubMed ID: 19142704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours.
    Melis M; Bijster M; de Visser M; Konijnenberg MW; de Swart J; Rolleman EJ; Boerman OC; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1968-76. PubMed ID: 19585115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats.
    Rolleman EJ; Bernard BF; Breeman WA; Forrer F; de Blois E; Hoppin J; Gotthardt M; Boerman OC; Krenning EP; de Jong M
    Nuklearmedizin; 2008; 47(3):110-5. PubMed ID: 18493690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide.
    de Jong M; Barone R; Krenning E; Bernard B; Melis M; Visser T; Gekle M; Willnow TE; Walrand S; Jamar F; Pauwels S
    J Nucl Med; 2005 Oct; 46(10):1696-700. PubMed ID: 16204720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
    Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
    J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localisation and mechanism of renal retention of radiolabelled somatostatin analogues.
    Melis M; Krenning EP; Bernard BF; Barone R; Visser TJ; de Jong M
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1136-43. PubMed ID: 15912401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion.
    Jamar F; Barone R; Mathieu I; Walrand S; Labar D; Carlier P; de Camps J; Schran H; Chen T; Smith MC; Bouterfa H; Valkema R; Krenning EP; Kvols LK; Pauwels S
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):510-8. PubMed ID: 12582815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches to Improve the Pharmacokinetics of Radiolabeled Glucagon-Like Peptide-1 Receptor Ligands Using Antagonistic Tracers.
    Rylova SN; Waser B; Del Pozzo L; Tönnesmann R; Mansi R; Meyer PT; Reubi JC; Maecke HR
    J Nucl Med; 2016 Aug; 57(8):1282-8. PubMed ID: 27127218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "To serve and protect": enzyme inhibitors as radiopeptide escorts promote tumor targeting.
    Nock BA; Maina T; Krenning EP; de Jong M
    J Nucl Med; 2014 Jan; 55(1):121-7. PubMed ID: 24287321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET imaging and biodistribution analysis of the effects of succinylated gelatin combined with L-lysine on renal uptake and retention of ⁶⁴Cu-cyclam-RAFT-c(-RGDfK-)₄ in vivo.
    Jin ZH; Furukawa T; Sogawa C; Claron M; Aung W; Tsuji AB; Wakizaka H; Zhang MR; Boturyn D; Dumy P; Fujibayashi Y; Saga T
    Eur J Pharm Biopharm; 2014 Apr; 86(3):478-86. PubMed ID: 24316338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of [111In-DTPA0]octreotide in the rat kidney is inhibited by colchicine and not by fructose.
    Rolleman EJ; Krenning EP; Van Gameren A; Bernard BF; De Jong M
    J Nucl Med; 2004 Apr; 45(4):709-13. PubMed ID: 15073269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.